Identification of regulators of poly-ADP-ribose polymerase inhibitor response through complementary CRISPR knockout and activation screens
Mutations in the homologous recombination proteins BRCA1 and BRCA2 can sensitize cells to treatment with inhibitors of poly-ADP-ribose polymerase 1 (PARPi), but resistance to the treatment can occur. Here the authors by genome-wide CRISPR knockout and activation screens reveal novel pathways of PARP...
Main Authors: | Kristen E. Clements, Emily M. Schleicher, Tanay Thakar, Anastasia Hale, Ashna Dhoonmoon, Nathanial J. Tolman, Anchal Sharma, Xinwen Liang, Yuka Imamura Kawasawa, Claudia M. Nicolae, Hong-Gang Wang, Subhajyoti De, George-Lucian Moldovan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-19961-w |
Similar Items
-
Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors.
by: Emily M Schleicher, et al.
Published: (2020-11-01) -
The Immunology of Poly (ADP-Ribose)
by: Okolie, E. E.
Published: (1978) -
Poly(ADP-ribose) glycohydrolase
by: Khoozani, M. T.
Published: (1983) -
Methods for Purification of Proteins Associated with Cellular Poly(ADP-Ribose) and PARP-Specific Poly(ADP-Ribose)
by: Rood, Jennifer E., et al.
Published: (2014) -
In Vivo Level of Poly(ADP-ribose)
by: Masanao Miwa, et al.
Published: (2018-05-01)